Cargando…
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
New drugs are needed to control the current tuberculosis (TB) pandemic caused by infection with Mycobacterium tuberculosis. We report here on our work with AX-35, an arylvinylpiperazine amide, and four related analogs, which are potent antitubercular agents in vitro. All five compounds showed good a...
Autores principales: | Foo, Caroline S., Lupien, Andréanne, Kienle, Maryline, Vocat, Anthony, Benjak, Andrej, Sommer, Raphael, Lamprecht, Dirk A., Steyn, Adrie J. C., Pethe, Kevin, Piton, Jérémie, Altmann, Karl-Heinz, Cole, Stewart T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178619/ https://www.ncbi.nlm.nih.gov/pubmed/30301850 http://dx.doi.org/10.1128/mBio.01276-18 |
Ejemplares similares
-
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
por: Lupien, Andréanne, et al.
Publicado: (2020) -
Improved Phenoxyalkylbenzimidazoles with Activity
against Mycobacterium tuberculosis Appear to Target
QcrB
por: Chandrasekera, N. Susantha, et al.
Publicado: (2017) -
Identification
of Morpholino Thiophenes as
Novel Mycobacterium tuberculosis Inhibitors, Targeting
QcrB
por: Cleghorn, Laura A. T., et al.
Publicado: (2018) -
Prediction of QcrB Inhibition as a Measure of Antitubercular
Activity with Machine Learning Protocols
por: Khan, Afreen A., et al.
Publicado: (2022) -
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
por: Abrahams, Katherine A., et al.
Publicado: (2012)